BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25773842)

  • 21. Management of brain metastases from non-small cell lung cancer.
    Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
    J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
    J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
    Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
    Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.
    Marko NF; Suh JH; Chao ST; Barnett GH; Vogelbaum MA; Toms S; Weil RJ; Angelov L
    J Neurooncol; 2011 Sep; 104(3):817-24. PubMed ID: 21431468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.
    Churilla TM; Handorf E; Collette S; Collette L; Dong Y; Aizer AA; Kocher M; Soffietti R; Alexander BM; Weiss SE
    Ann Oncol; 2017 Oct; 28(10):2588-2594. PubMed ID: 28961826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
    Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
    Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
    Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
    Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
    Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
    Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three treatment options for single brain metastasis from lung cancer.
    Li B; Yu J; Suntharalingam M; Kennedy AS; Amin PP; Chen Z; Yin R; Guo S; Han T; Wang Y; Yu N; Song G; Wang L
    Int J Cancer; 2000 Feb; 90(1):37-45. PubMed ID: 10725856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain Metastases.
    Bhave VM; Lamba N; Tjong MC; Aizer AA; Bi WL
    Neurosurgery; 2024 Jan; 94(1):117-128. PubMed ID: 37489905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC.
    Li L; Feng M; Xu P; Wu YL; Yin J; Huang Y; Tan MY; Jinyi L
    Int J Neurosci; 2023 Mar; 133(3):334-341. PubMed ID: 33843421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
    Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
    Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.